Low Voltage-Directed Catheter Ablation for Atrial Fibrillation (LD-CAF)

Principal Investigator: Dr. Nikhil Panda
Study Coordinator: Joe Manacop and Maureen Dempsey ​

​This is a prospective, multi-center, randomized study comparing the protocol specified ablation approach to the current standardized ablation approach in the treatment of non-paroxysmal atrial fibrillation. The purpose is to evaluate long term success of non-paroxysmal atrial fibrillation ablation when using a 1) specified low voltage-directed catheter ablation with pulmonary vein isolation (LD +PVI) approach compared to 2) pulmonary vein isolation (PVI) alone.

This study is actively enrolling patients. To learn more about LD-CAF and how you can join contact our research office at (314) 289-7690

This study is funded by the Foundation through The MetroHealth System; Biosense Webster, Inc.